Combined inhaled nitric oxide and inhaled prostacyclin during experimental chronic pulmonary hypertension

Journal of Applied Physiology

Volumn 86, Issue 4, 1999, Pages 1160-1164

  Hill, Laureen L ^a   Pearl, Ronald G ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenosine 3',5' cyclic monophosphate; Guanosine 3',5' cyclic monophosphate; Monocrotaline; Pulmonary vascular resistance; Rat; Vasodilator

Indexed keywords

NITRIC OXIDE; PROSTACYCLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; INHALATIONAL DRUG ADMINISTRATION; LUNG VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; VASODILATATION;

EID: 0032908062     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1999.86.4.1160     Document Type: Article

References (40)

1. Aranda, M. K. K., and R. G. Pearl. Combined therapy with inhaled nitric oxide and intravenous vasodilators during experimental pulmonary hypertension (Abstract). Anesthesiology 87: A1123, 1997.
2. Bigatello, L. M., W. E. Hurford, R. M. Kacmarek, J. D. Roberts, Jr., and W. M. Zapol. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Effects on pulmonary hemodynamics and oxygenation. Anesthesiology 80: 761-770, 1994.
3. Booke, M., D. W. Bradford, F. Hinder, D. Harper, R. W. Brauchle, L. D. Traber, and D. L. Traber. Effects of inhaled nitric oxide and nebulized prostacyclin on hypoxic pulmonary vasoconstriction in anesthetized sheep. Crit. Care Med. 24: 1841-1848, 1996.
4. Channick, R. N., R. C. Hoch, J. W. Newhart, F. W. Johnson, and C. M. Smith. Improvement in pulmonary hypertension and hypoxemia during nitric oxide inhalation in a patient with end-stage pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 149: 811-814, 1994.
5. De Wit, C., P. von Bismarck, and U. Pohl. Synergistic action of vasodilators that increase cGMP and cAMP in the hamster cremaster microcirculation. Cardiovasc. Res. 28: 1513-1518, 1994.
6. Emil, S. G., J. E. Berkeland, and J. B. Atkinson. Nitric oxide dose response during moderate and severe hypoxia in swine. Ann. Thorac. Surg. 63: 414-418, 1997.
7. Emil, S., M. Kosi, J. Berkeland, S. Kanno, C. Newth, and J. Atkinson. Severity of hypoxia predicts response to nitric oxide in a porcine pulmonary hypertension model. J. Pediatr. Surg. 30: 930-935; discussion 935-936, 1995.
8. Etches, P. C., N. N. Finer, K. J. Barrington, A. J. Graham, and W. K. Chan. Nitric oxide reverses acute hypoxic pulmonary hypertension in the newborn piglet. Pediatr. Res. 35: 15-19, 1994.
9. Frostell, C., M. D. Fratacci, J. C. Wain, R. Jones, and W. M. Zapol. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038-2047, 1991. [Corrigenda. Circulation 84: November 1991, p. 2212].
10. Fuller, H. D., M. B. Dolovich, G. Posmituck, W. W. Pack, and M. T. Newhouse. Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Comparison of dose to the lungs. Am. Rev. Respir. Dis. 141: 440-444, 1990.
11. Gillespie, M. N., W. B. Frederick, R. J. Altiere, J. W. Olson, and E. C. Kimmel. Pulmonary mechanical, ventilatory, and gas exchange abnormalities in rats with monocrotaline-induced pulmonary hypertension. Exp. Lung Res. 8: 191-199, 1985.
12. Haraldsson, A., N. Kieler-Jensen, and S. E. Ricksten. Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. J. Cardiothorac. Vasc. Anesth. 10: 864-868, 1996.
13. Ichida, F., K. Uese, I. Hashimoto, Y. Hamamichi, S. Tsubata, K. Fukahara, A. Murakami, and T. Miyawaki. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children. J. Cardiol. 29: 217-224, 1997.
14. Ichida, F., K. Uese, S. Tsubata, I. Hashimoto, Y. Hamamichi, K. Fukahara, A. Murakami, and T. Miyawaki. Additive effect of beraprost on pulmonary vasodilation by inhaled nitric oxide in children with pulmonary hypertension. Am. J. Cardiol. 80: 662-664, 1997.
15. 2. J. Appl. Physiol. 45: 408-413, 1978.
16. Katayama, Y., K. Hatanaka, T. Hayashi, K. Onoda, I. Yada, S. Namikawa, H. Yuasa, M. Kusagawa, K. Maruyama, and M. Kitabatake. Effects of inhaled nitric oxide in rats with chemically induced pulmonary hypertension. Respir. Physiol. 97: 301-307, 1994.
17. MacIntyre, N. R., R. M. Silver, C. W. Miller, F. Schuler, and R. E. Coleman. Aerosol delivery in intubated, mechanically ventilated patients. Crit. Care Med. 13: 81-84, 1985.
18. Mattocks, A. Toxicity of pyrrolizidine alkaloids. Nature 217: 723-728, 1968.
19. Molteni, A., W. F. Ward, C. H. Ts'ao, and J. M. Hinz. Monocrotaline-induced cardiopulmonary injury in rats. Modification by the neutrophil elastase inhibitor SC39026. Biochem. Pharmacol. 38: 2411-2419, 1989.
20. Molteni, A., W. F. Ward, C. H. Ts'ao, C. D. Port, and N. H. Solliday. Monocrotaline-induced pulmonary endothelial dysfunction in rats. Proc. Soc. Exp. Biol. Med. 176: 88-94, 1984.
21. Molteni, A., W. F. Ward, C. H. Ts'ao, N. H. Solliday, and M. Dunne. Monocrotaline-induced pulmonary fibrosis in rats: amelioration by captopril and penicillamine. Proc. Soc. Exp. Biol. Med. 180: 112-120, 1985.
22. Neonatal Inhaled Nitric Oxide Study Group. Inhaled, nitric oxide in full-term, and nearly full-term infants with hypoxic respiratory failure. N. Engl. J. Med. 336: 597-604, 1997.
23. Olschewski, H., D. Walmrath, R. Schermuly, A. Ghofrani, F. Grimminger, and W. Seeger. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann. Intern. Med. 124: 820-824, 1996.
24. Pepke-Zaba, J., T. W. Higenbottam, A. T. Dinh-Xuan, D. Stone, and J. Wallwork. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 338: 1173-1174, 1991.
25. Pison, U., F. A. Lopez, C. F. Heidelmeyer, R. Rossaint, and K. J. Falke. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J. Appl. Physiol. 74: 1287-1292, 1993.
26. 1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension. Crit. Care Med. 19: 60-67, 1991.
27. Roberts, J. D., Jr., J. R. Fineman, F. C. Morin III, P. W. Shaul, S. Rimar, M. D. Schreiber, R. A. Polin, M. S. Zwass, M. M. Zayek, I. Gross, M. A. Heymann, and W. M. Zapol. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N. Engl. J. Med. 336: 605-610, 1997.
28. Rossaint, R., K. J. Falke, F. Lopez, K. Slama, U. Pison, and W. M. Zapol. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 328: 399-405, 1993.
29. Rossaint, R., H. Gerlach, H. Schmidt-Ruhnke, D. Pappert, K. Lewandowski, W. Steudel, and K. Falke. Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest 107: 1107-1115, 1995.
30. Rubin, L. J., B. M. Groves, J. T. Reeves, M. Frosolono, F. Handel, and A. E. Cato. Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension. Circulation 66: 334-338, 1982.
31. Shimokawa, H., N. A. Flavahan, R. R. Lorenz, and P. M. Vanhoutte. Prostacyclin releases endothelium-derived relaxing factor and potentiates its action in coronary arteries of the pig. Br. J. Pharmacol. 95: 1197-1203, 1988.
32. Thomas, S. H., M. J. O'Doherty, H. M. Fidler, C. J. Page, D. F. Treacher, and T. O. Nunan. Pulmonary deposition of a nebulised aerosol during mechanical ventilation. Thorax 48: 154-159, 1993.
33. Van Obbergh, L. J., M. Charbonneau, and G. Blaise. Combination of inhaled nitric oxide with i.v. nitroglycerin or with a prostacyclin analogue in the treatment of experimental pulmonary hypertension. Br. J. Anaesth. 77: 227-231, 1996.
34. Walmrath, D., T. Schneider, J. Pilch, F. Grimminger, and W. Seeger. Aerosolised prostacyclin in adult respiratory distress syndrome [see comments]. Lancet 342: 961-962, 1993.
35. Walmrath, D., T. Schneider, R. Schermuly, H. Olschewski, F. Grimminger, and W. Seeger. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 153: 991-996, 1996.
36. Weitzberg, E., A. Rudehill, K. Alving, and J. M. Lundberg. Nitric oxide inhalation selectively attenuates pulmonary hypertension and arterial hypoxia in porcine endotoxin shock. Acta Physiol. Scand. 143: 451-452, 1991.
37. 2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur. Surg. Res. 25: 329-340, 1993.
38. Wessel, D. L., I. Adatia, T. M. Giglia, J. E. Thompson, and T. J. Kulik. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 88: 2128-2138, 1993.
39. Zobel, G., D. Dacar, S. Rodl, and I. Friehs. Inhaled nitric oxide versus inhaled prostacyclin and intravenous versus inhaled prostacyclin in acute respiratory failure with pulmonary hypertension in piglets. Pediatr. Res. 38: 198-204, 1995.
40. 2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154: 1671-1677, 1996.